Don Pham is a Principal Scientist specializing in Preclinical Pharmacology with the Eli Lilly Genetic Medicine Team, a position held since 2023. Previously, Pham served as a Research Scientist II at Novartis Institutes for BioMedical Research from 2017 to 2023, focusing on Respiratory In Vivo Translational Pharmacology. Pham's experience also includes roles as a Contract Research Associate I at EMD Serono, Inc. in 2016, and a Research Associate I at Toxikon Corporation. Pham began their career in the biotechnology field with a B.S. in Biotechnology from the University of Massachusetts Lowell, where they graduated in 2015.
This person is not in the org chart
This person is not in any teams
This person is not in any offices